Project Steering Group

Chaired by Professor Frank Bonner, the PSG is composed of the Principal Investigators and their research teams, as well as representatives of the public and private sectors, and the Chair of the Scientific Advisory Board.

Professor Frank BonnerChief Executive

Professor Frank Bonner was appointed Chief Executive of Stem Cells for Safer Medicines in July, 2009 and led a successful funding effort with the private and public sectors which provided support for the current research campaign.

Dr Chris Goldring

Principle Investigator, University of Liverpool

Chris Goldring has nearly twenty years of experience of molecular bioanalysis and has largely focused on understanding transcriptional control in the liver. He has been a panel member of Biotech grant committees for Enterprise Ireland, and he leads teaching programmes on Safety Pharmacology and Stem Cells in the Innovative Medicines Initiative Safescimet training programme.

Professor Neil Hanley

Principle Investigator, University of Manchester

Professor Neil Hanley (FRCP, PhD) is a Professor of Medicine, Wellcome Trust Senior Fellow in Clinical Science, Head of the Centre for Endocrinology & Diabetes, and Director of the Fellowship Academy in the Faculty of Medical & Human Sciences at the University of Manchester.

Professor David Tosh

Principal Investigator, University of Bath

Professor David Tosh received his PhD in the Department of Medicine, University of Newcastle-upon-Tyne. He then moved to the University of Dundee to carry out research in Professor Brian Burchell’s laboratory at Ninewells Hospital. In 1994, he moved to the University of Bath and is now Professor of Stem Cell and Regenerative Biology and Director of the Bath Centre for Regenerative Medicine.